BusinessUpdated 26 min ago
Natco Pharma gets USFDA’s EIR for Visakhapatnam plant

August inspection drew four Form-483 observations; regulator classifies as Voluntary Action Indicated
Continue reading on BusinessLine
Read full story Hello Headlines links you to the original publisher for the full story.

